Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease

Nephrology

Volumn 13, Issue 2, 2008, Pages 153-156

  Malyszko, Jolanta ^a   Bachorzewska Gajewska, Hanna ^a   Malyszko, Jacek S ^a   Pawlak, Krystyna ^a   Dobrzycki, Slawomir ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Cystatin C; Hypertension; Kidney function; Neutrophil gelatinase associated lipocalin (NGAL)

Indexed keywords

CREATININE; CYSTATIN C; HEMOGLOBIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; UREA;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; EARLY DIAGNOSIS; FEMALE; GLOMERULUS FILTRATION RATE; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN URINE LEVEL; RENOVASCULAR HYPERTENSION; UNIVARIATE ANALYSIS; UREA BLOOD LEVEL;

ACUTE-PHASE PROTEINS; ADULT; AGED; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; CREATININE; CYSTATINS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY DISEASES; LIPOCALINS; MALE; MIDDLE AGED; PILOT PROJECTS; PROTO-ONCOGENE PROTEINS; REPRODUCIBILITY OF RESULTS; UP-REGULATION;

EID: 39049085865     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2007.00899.x     Document Type: Article

References (22)

1. Ruilope LM, Segura J, Campo C, Rodicio JL. Renal participation in cardiovascular risk in essential hypertension. Expert Rev. Cardiovasc. Ther. 2003 1 : 309 15.
2. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002 360 : 1903 13.
3. Bellomo R, Kellum JA, Ronco C. Defining acute renal failure: Physiological principles. Intensive Care Med. 2004 30 : 33 7.
4. Al Suwaidi J, Reddan DN, Williams K et al. GUSTO-IIb, GUSTO-III, PURSUIT. Global Use of Strategies to Open Occluded Coronary Arteries. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy; PARAGON-A Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002 106 : 974 80.
5. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J. Biol. Chem. 1993 268 : 10425 32.
6. Cowland JB, Borregaard N. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 1997 45 : 17 23.
7. Mishra J, Dent C, Tarabishi R et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005 365 : 1231 8.
8. Mori K, Lee HT, Rapoport D et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J. Clin. Invest. 2005 115 : 610 21.
9. Hojs R, Bevc S, Ekart R, Gorenjak M, Puklavec L. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function. Nephrol. Dial. Transplant. 2006 21 : 1855 62.
10. Modification of diet in Renal Disease Study Group. Creatinine filtration, secretion and excretion during progressive renal disease. Kidney Int. 1989 36 : S73 80.
11. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976 16 : 31 41.
12. Mitsnefes MM, Kathman TS, Mishra J et al. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease. Pediatr. Nephrol. 2007 22 : 101 8.
13. Okusa MD. The inflammatory cascade in acute ischemic renal failure. Nephron 2002 90 : 133 8.
14. Hemdahl AL, Gabrielsen A, Zhu C et al. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 2006 26 : 136 42.
15. Bachorzewska-Gajewska H, Malyszko J, Malyszko JS, Musial W, Dobrzycki S. Undiagnosed renal impairment in patients with and without diabetes with normal serum creatinine undergoing percutaneous coronary intervention. Nephrology (Carlton) 2006 11 : 549 54.
16. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Dobrzycki S. NGAL (neutrophil gelatinase-associated lipocalin) and renal function after percutaneous coronary interventions. Am. J. Nephrol. 2006 26 : 287 93.
17. Paulsson J, Dadfar E, Held C, Jacobson SH, Lundahl J. Activation of peripheral and in vivo transmigrated neutrophils in patients with stable coronary artery disease. Atherosclerosis 2007 192 : 328 34.
18. Mori K, Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int. 2007 71 : 967 70.
19. Fried LF, Katz R, Sarnak MJ et al. Kidney function as a predictor of noncardiovascular mortality. J. Am. Soc. Nephrol. 2005 16 : 3728 35.
20. Mishra J, Ma Q, Prada A et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J. Am. Soc. Nephrol. 2003 14 : 2534 43.
21. Ding H, He Y, Li K et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin. Immunol. 2007 12 : 227 34.
22. Bolignano D, Coppolino G, Campo S et al. Neutrophil Gelatinase-Associated Lipocalin in Patients with Autosomal-Dominant Polycystic Kidney Disease. Am. J. Nephrol. 2007 27 : 373 8.